Related Experiment Video
Updated: Jun 18, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis
Daxing Xie1, Crystal Gore, Jian Zhou
1Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Abstract:
In metastatic prostate cancer (PCa) cells, imbalance between cell survival and death signals such as constitutive activation of phosphatidylinositol 3-kinase (PI3K)-Akt and inactivation of apoptosis-stimulated kinase (ASK1)-JNK pathways is often detected. Here, we show that DAB2IP protein, often down-regulated in PCa, is a potent growth inhibitor by inducing G(0)/G(1) cell cycle arrest and is proapoptotic in response to stress. Gain of function study showed that DAB2IP can suppress the PI3K-Akt pathway and enhance ASK1 activation leading to cell apoptosis, whereas loss of DAB2IP expression resulted in PI3K-Akt activation and ASK1-JNK inactivation leading to accelerated PCa growth in vivo. Moreover, glandular epithelia from DAB2IP(-/-) animal exhibited hyperplasia and apoptotic defect. Structural functional analyses of DAB2IP protein indicate that both proline-rich (PR) and PERIOD-like (PER) domains, in addition to the critical role of C2 domain in ASK1 activity, are important for modulating PI3K-Akt activity. Thus, DAB2IP is a scaffold protein capable of bridging both survival and death signal molecules, which implies its role in maintaining cell homeostasis.
Insights
DAB2IP protein suppresses prostate cancer (PCa) growth by halting cell cycles and promoting apoptosis. Its loss activates survival pathways, accelerating PCa progression and causing hyperplasia.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Metastatic prostate cancer (PCa) often shows dysregulated cell survival (PI3K-Akt pathway) and death (ASK1-JNK pathway) signaling.
- DAB2IP protein is frequently downregulated in PCa, suggesting a role in cancer progression.
Purpose of the Study:
- To investigate the role of DAB2IP protein in prostate cancer growth and cell death signaling.
- To elucidate the molecular mechanisms by which DAB2IP modulates survival and death pathways.
Main Methods:
- Gain-of-function and loss-of-function studies of DAB2IP in PCa cells.
- Analysis of cell cycle progression, apoptosis, and signaling pathways (PI3K-Akt, ASK1-JNK).
- In vivo studies using DAB2IP knockout animal models and structural functional analysis of DAB2IP protein domains.
Main Results:
- DAB2IP functions as a potent growth inhibitor, inducing G(0)/G(1) cell cycle arrest and apoptosis.
- DAB2IP suppresses PI3K-Akt signaling and enhances ASK1 activation, promoting apoptosis.
- Loss of DAB2IP leads to PI3K-Akt activation, ASK1-JNK inactivation, accelerated PCa growth, hyperplasia, and apoptotic defects in vivo.
Conclusions:
- DAB2IP acts as a crucial tumor suppressor in prostate cancer by balancing cell survival and death signals.
- DAB2IP's proline-rich, PERIOD-like, and C2 domains are critical for its function in modulating PI3K-Akt and ASK1 pathways.
- DAB2IP functions as a scaffold protein, maintaining cellular homeostasis and implying therapeutic potential in PCa.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
IP3/DAG Signaling Pathway
The JAK-STAT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage Can Stall the Cell Cycle